SKSabrina Khalfoun

Sabrina Khalfoun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Sabrina Khalfoun has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Dmitry Tumin

    Department of Pediatrics, Brody School of Medicine, East Carolina University, Greenville, NC, USA

    1 shared publication
  • Don Hayes

    Division of Pediatrics, Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA

    1 shared publication
  • Maroun Ghossein

    Division of Pulmonary and Critical Care, Medical College of South Carolina, Charleston, South Carolina, USA

    1 shared publication
  • Meredith Lind

    Division of Pediatrics, Section of Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA

    1 shared publication
  • Stephen Kirkby

    Division of Pediatrics, Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA

    1 shared publication

Latest Publications

  • Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction

    by Sabrina Khalfoun, Dmitry Tumin, Maroun Ghossein, Meredith Lind, Don Hayes, Stephen Kirkby

    Cystic fibrosis (CF) is characterized by infection and inflammation of the sinorespiratory tract. Functional endoscopic sinus surgery (FESS) is an option for patients with severe sinusitis. We sought to evaluate pulmonary function testing after FESS in pediatric and adult patients with CF. Retrospective chart review using data from all patients with CF who underwent FESS from January 2009 to July 2014. Patients were from a single institution. Data were extracted for 181 patients and 320 surgeries. Lung function data, including the forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC, were retrieved within 1 year before and after surgery. Mixed-effects regression was used to compare FEV1 trajectories before and after surgery. The effect of surgery was stratified by presurgery FEV1 to compare patients with mild/no lung disease (FEV1 >80%) and moderate/severe lung disease (FEV1 80% and 43 patients with FEV1 <80%. For the entire cohort, lung function did not change related to FESS. Among patients with FEV1 80%. Pulmonary function testing improved in patients with moderate/severe lung disease 1 year following FESS. This suggests FESS may benefit pulmonary outcomes.